News | SNMMI | February 06, 2024

This year’s Mid-Winter Conference of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) drew global experts exchanging the latest innovations in diagnostic and molecular imaging, cancer therapies, clinical trials and theranostics, as well as the potential role of artificial intelligence (AI) in nuclear medicine during the Feb. 1-3, 2024 meeting in Orlando, FL.

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2024 Mid-Winter Conference drew global experts exchanging the latest innovations in diagnostic and molecular imaging, cancer therapies, clinical trials and theranostics, as well and the role of artificial intelligence (AI) in nuclear medicine during its Feb. 1-3, 2024 meeting in Orlando, FL.

This 2024 Mid-Winter Conference of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) drew global experts exchanging the latest innovations in diagnostic and molecular imaging, cancer therapies, clinical trials and theranostics, as well as the potential role of artificial intelligence (AI) in nuclear medicine during the Feb. 1-3, 2024 meeting in Orlando, FL. Image courtesy: SNMMI


February 6, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) held its 2024 SNMMI Mid-Winter Meeting in Orlando, FL from Feb. 1-3, drawing more than 700 nuclear medicine physicians, pharmacists, scientists, technologists, laboratory professionals, and industry partners from around the world. gathered in Orlando, Florida, on February 1-3 for the SNMMI Mid-Winter meetng. The meeting is held each year in conjunction with the American College of Nuclear Medicine Annual Meeting, ACNM 2024, and offered attendees the chance to learn from experts in the field and enhance their skills in order to provide the best possible care for patients. 

This year’s SNMMI Mid-winter meeting and ACNM Meeting included three distinct educational tracks, according to a written overview issued by SNMMI. Those tracks included: an ACNM Annual Meeting track focused on molecular imaging; a radiopharmaceutical therapy specialty track covering various therapies, as well as operationalizing a therapy center; and a general nuclear medicine track with sessions on diagnostic imaging innovations, clinical trials, dosimetry, among other key areas.

The SNMMI Therapy Specialty Track included a session on “Setting up a Theranostic Center: From Business Planning to Daily Operation – Dosimetry and Case Review,” as well as “Theranostics Moving Forward: New Targets and Combination Therapy.” The SNMMI General Nuclear Medicine Track featured the following sessions, among others: “Pediatric Imaging – Tips for Optimization and Diagnosis,” and “Nuts and Bolts: Becoming a Clinical Trial Site.”

Additionally, the PIDCS/AC/AI Task Force presented a session, “Unleashing the Potential: Artificial Intelligence (AI)’s Role in Revolutionizing NM Instrumentation, Clinical Tasks, and Non-Clinical Tasks.” The Physics, Instrumentation and Data Sciences Council (PIDSC) is composed of Society members who have an interest in medical physics, nuclear instrumentation, and data analysis and their applications in therapeutic, diagnostic or investigational nuclear medicine. SNMMI also noted that of particular interest were sessions on clinical implementation of cutting-edge therapy research, such as alpha therapy, peptide receptor radionuclide therapy, prostate cancer therapy, new targets and combination therapy. 

Six satellite symposia were offered on topics including brain and prostate cancer imaging and insights into the new era of molecular imaging, noted the Society’s post-meeting overview. Relatedly, programs on radiation oncology challenges included sessions on focused areas of imaging: breast, prostate, lung, brain; MRI and PET scans; as well as pediatric imaging, and the impact of therapies as it relates to imaging young cancer patients for cardiovascular risks.

More than 40 nuclear medicine and molecular imaging companies were represented in the sold-out exhibit hall, offering attendees the chance to converse directly with industry professionals and explore the latest technologies and products available in the field.

The ACNM Annual Meeting provided an opportunity for attendees to present new research; 107 abstracts were accepted, 20 as oral presentations and 87 as posters. The College also presented its annual awards, including the ACNM Gold Medal to Richard Wahl, MD; Lifetime Achievement, Michael Knopp, MD, PhD; Best Personal Mentor, David Mankoff, MD, PhD; Best Clinical Mentor, Erica Cohen Major, DO, MPH; and Mandell-Alavi Lectureship, Lisa Bodei, MD, PhD.

“The expertise and breadth of information included in this meeting attracted attendees from around the world, and the intimate setting was ideal for networking with peers,” said Heather Jacene, MD, chair of the SNMMI Scientific Program Committee. She added, “By all accounts this year’s meeting was a success, and we look forward to meeting with our colleagues again at the SNMMI Annual Meeting in June.” Jacene, of the Dana-Farber Cancer Institute, also holds the roles of Clinical Director, Nuclear Medicine/PET-CT; Associate Program Director, Brigham and Women's BWH Joint Program in Nuclear Medicine (JPNM) Senior Physician; and Associate Professor of Radiology, Harvard Medical School.

The 2024 SNMMI Annual Meeting will be held June 8-11, in Toronto, Ontario, Canada.  As noted by the organization, the Reston, VA-based Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging — vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. Members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice.

More information: www.snmmi.org

Find more SNMMI24 conference coverage here

Related content:

JNM Publishes Procedure Standard/practice Guideline for FES PET Imaging of Breast Cancer

SNMMI Issues Updated Statement: COVID-19 and V/Q Lung Studies

SNMMI Keeps “Eye on the Patient” at 2023 Annual Meeting

Society of Nuclear Medicine and Molecular Imaging Names Helen Nadel, MD, FRCPC, of Stanford, as President, Announces New Officers at SNMMI 2023 Annual Meeting


Related Content

News | ASTRO

June 21, 2024 — The American Society for Radiation Oncology (ASTRO) announced today that following a nationwide search ...

Time June 21, 2024
arrow
News | Nuclear Imaging

June 20, 2024 — GE HealthCare joined the world’s top medical and academic institutions at the Society of Nuclear ...

Time June 20, 2024
arrow
News | SIIM

June 20, 2024 — The Society for Imaging Informatics in Medicine (SIIM) is gearing up for its SIIM24 Annual Meeting and ...

Time June 20, 2024
arrow
News | Mobile C-Arms

June 19, 2024 —Royal Philips, a global leader in health technology, today announced the launch of Philips Image Guided ...

Time June 19, 2024
arrow
News | Artificial Intelligence

June 18, 2024 — The advancement of Artificial Intelligence (AI) in healthcare to support diagnostic decision making ...

Time June 18, 2024
arrow
News | PET Imaging

June 18, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 18, 2024
arrow
News | Lung Imaging

June 18, 2024 — A new study led by American Cancer Society (ACS) researchers shows less than one-in-five eligible ...

Time June 18, 2024
arrow
News | Ultrasound Women's Health

June 18, 2024 — The International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) has announced details of ...

Time June 18, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

June 17, 2024 — MRI has transformed neuroscience research over the past 50 years, but research participants have had to ...

Time June 17, 2024
arrow
News | Radiology Business

June 17, 2024 — Strategic Radiology welcomed Northwest Radiologists, Inc, a 20-radiologist practice based in Bellingham ...

Time June 17, 2024
arrow
Subscribe Now